A carregar...
Intranasal Interferon-α2b for Seasonal Prophylaxis of Respiratory Infection
Efficacy of intranasal recombinant alpha interferon (IFN-α2b) was evaluated over a four-week period. The first 400 participants received either 1,500,000 IU of IFN-α2b or placebo twice daily. Rhinovirus infections were prevented (protective efficacy, 76%). Parainfluenza infections were not prevented...
Na minha lista:
| Publicado no: | J Infect Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The University of Chicago Press
1986
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109820/ https://ncbi.nlm.nih.gov/pubmed/3011917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/154.1.128 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|